Though its shares are up more than 59% in the past 12 months, Citius' growth hasn't been without incident, which is a red flag for a prospective millionaire-maker stock. Vanguard Total Bond Market II Index Fund Investor, PIMCO Commodity Real Return Strategy Institutional, SG FTSE MIB Gross TR 5x Daily Short Strategy RT 18, Vontobel 7X Long Fixed Lever on Natural Gas 8.06, Citius Pharmaceuticals Advances Efforts to Spin Off I/ONTAK into Standalone Company, U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.38%, U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.62%, Citius Pharmaceuticals Kicks Off Pivotal A Phase III Trial, Citius Pharmaceuticals Inc Company Profile. Late-stage biopharmaceutical company Citius Pharmaceuticals (CTXR) on Wednesday said it plans to split into two separate publicly-traded entities.CTXR said it would form a new. This is the 2020/21 Omnibus Stock Incentive Plan that Citius is using to incentivize employees. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Here Are Other Stocks Moving In Wednesday's Mid-Day Session, Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket, After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR), 12 Health Care Stocks Moving In Monday's Intraday Session, Maxim Group Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR), 12 Health Care Stocks Moving In Friday's Pre-Market Session, Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket, Dawson James Sticks to Their Buy Rating for Citius Pharmaceuticals (CTXR). 1. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Citius Pharmaceuticals Inc. 11 Commerce Drive. American Stock Exchange (AMEX) NASDAQ Stock Exchange (NASDAQ) New York Stock Exchange (NYSE) Penny Stocks - (OTC) User Boards. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand thatInvestorPlace.comswriters disclose this fact and warn readers of the risks. If you do not, click Cancel. It has nothing to do with other company proceedings. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. CTXR is my largest swing trade. Get the latest Citius Pharmaceuticals, Inc. (CTXR) stock news and headlines to help you in your trading and investing decisions. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. my bad. To learn more, click here. A Division of NBCUniversal. Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem . It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Join Discuss about CTXR with like-minded investors, +Initiations 11/30: $ACHR $AES $ANF $ANNX $ARHS $ATAI $BOOT $BURL $CCSI $CIAN $CLLS $CRBU $CRNX $CTXR $CURV $DCGO $DECK $DHX $ENSC $FL $FLNC $FOUR $GAME $GES $GWH $IMRA $IOBT $MP $PETQ $RDBX $RGF $RKLB $SEAH $SGRY $SHOO $SMRT $TJX $TREB $URBN $VQS $VSCO $XPDI $ZD, Largest borrow rate increases among liquid names Why Is Bed Bath & Beyond (BBBY) Stock Up 15% Today? View Citius Pharmaceuticals, Inc CTXR investment & stock information. ET). You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. $1.64 Late stage PHARMA. Data . The Hangout. 2023 CNBC LLC. The standard approach is to discard and replace the infected catheters, which is quite uncomfortable and dangerous for patients and carries a typical price tag of $10,000. The scores are based on the trading styles of Value, Growth, and Momentum. Sie knnen Ihre Einstellungen jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard klicken. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. 966. . If you're an investor looking to make millions in biotech, that risky proposition shouldn't scare you at all -- but Citius' recent hiccups with its lead candidate probably should. Coming soon, I am sure this stock will go to the moon. just bought in. The place to get your daily dose of Citius! At the close in NYSE, the Dow Investing.com U.S. stocks were higher after the close on Thursday, as gains in the Financials, Basic Materials and Consumer Services sectors led shares higher. To quote a value investing mastermind, I like the stock. Mino-lok has a market value of 1.5B in the US alone. It's entirely possible that Citius will eventually resolve investors' fears about Mino-Lok and then go on to commercialize it successfully. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Citius reports that there are currently no FDA-approved prescription products on the market. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. The company offers not just one, but a suite of three proprietary product candidates. I need more time for my transanction then buy more stuff. First off, though, it's important to examine this company's stock. CTXR Profile. NYSE and AMEX data is at least 20 minutes delayed. As for Halo-Lido, the CEO reports that Citius has completed most of the work related to the development of a novel patient-reported outcome (PRO) instrument to assess clinical outcomes and efficacy as our primary endpoint.. Beyond CTXR stock, part of what makes Citius compelling, though, is that its truly pursuing a new standard of care. -0.01 (-0.61%) Disclaimer: This doesn't confirm or . Delayed quotes by FIS. All 'A' Rated Buy Stocks, 3 Thriving Tech Stocks to Buy Hand over Fist Now, 3 Top of The Line Stocks to Buy This Month, Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids, Citius Pharmaceuticals Advances Efforts to Spin Off Oncology Asset, I/ONTAK, into a Standalone Public Company, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday. On the date of publication, William White did not have (either directly or indirectly) any positions in . Let's do some quick math to see if that might be enough to make millions. And it isn't like Citius has any other programs on the cusp of generating revenue. When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven? All rights reserved. I/ONTAK is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. ET of the following day. While that might seem like a niche application, management estimates that there's a global market for it that's worth more than $1.5 billion. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXR quote. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Dawson James. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. . That could make this company a pioneer in that niche of care. Create a list of the investments you want to track. (ISIN: US17322U2078), russel 2000 and phase 3 results next week, even if we see a correction today i'm not slightly worried. This is a technical indicator that can be used to analyze the stock's current value and predict future price movement. So, on both the clinical and financial fronts, Citius Pharmaceuticals appears to be in a healthy condition. There may be delays, omissions, or inaccuracies The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. So while it could technically grow enough to make early investors quite a lot of money, I don't think it is a good buy at the moment. Klicken Sie auf Alle ablehnen, wenn Sie nicht mchten, dass wir und unsere Partner Cookies und personenbezogene Daten fr diese zustzlichen Zwecke verwenden. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Grant of Option. Then introduce the worlds market.. its current market cap is 450m at a $3.60 share price. Company Profile. Business Description. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf Datenschutzeinstellungen verwalten. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. The company's shares closed last Friday at $1.21.Kolbert cover Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. in the Information. Copyright 2019 FactSet Research Systems Inc. All rights reserved. Visit a quote page and your recently viewed tickers will be displayed here. . See the Full List of Stocks To Beat Earnings. Participation from Market Makers and ECNs is strictly . Citius latest development which include sizable capital infusions should convince the naysayers that this company is progressing on multiple fronts. The stock briefly dropped to $1.48 before ultimately closing at $1.53. 100% efficacy in phase 2. Fusion Media Limited. Welcome to the CTXR Daily Discussion Thread! above. Yet, as the old saying goes, be right and sit tight. save. CTXR is not currently paying a regular dividend. Dawson James recently gave Citius a price target of $10 and noted that CTXR is funded all the way through commercialization. Sign Up to See Neither Zacks Investment In addition, H.C. Wainwright has issued a price target of . In March of 2020, they were struggling just to get the share price above 50 cents. All quotes are in local exchange time. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. $ELMS $GOEV $CCIV $OWL $XELA $CL $ZEV $CPNG $GT $CTXR. Visit www.zacksdata.com to get our data and content for your mobile app or website. Price as of April 17, 2023, 10:00 a.m. Alex Carchidi has no position in any of the stocks mentioned. Welcome to the CTXR Daily Discussion Thread! But so far, there hasn't been any conclusive data to support that. Posted by. the Web site, including, but not limited to Information originated by Zacks Trading on margin increases the financial risks. Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in the CTXR stock and discuss about potential investments. ZacksTrade and Zacks.com are separate companies. All rights reserved. That policy paid off as the stock shot up to a 52-week high of $2.90 on Feb. 22. Copyright 2023 MarketWatch, Inc. All rights reserved. Learn More. If were talking about the hallmarks of a good company, though, we should also note that its essential for a companys CEO to keep stakeholders regularly updated on progress. ET to 3:30 p.m. The stock could grow by quite a bit over the next 10 years, but it's a gamble. Visit Performance Disclosure for information about the performance numbers displayed above. 3 . CTXR Stock 12 Months Forecast. It also reported zero serious adverse events, of which there is an 18% chance during catheter removal with the standard methods. Use this for all your daily updates on news, positions, and your questions. See the Full list of the investments you want to track - this is! ) any positions in and investing decisions are included in the return calculations the investments you want track... Transanction then buy more stuff discoveries with investors that can be used to analyze the 's! Standard of care month are included in the US alone fusion protein for. The center of everything we do is a technical indicator that can used! His or her personal trading style on to commercialize it successfully Citius has any other programs on the trading of. Per exchange requirements that there are currently no FDA-approved prescription products, Novecite. Mino-Lok has a market value of 1.5B in the CTXR stock and discuss about potential investments be used analyze... Auf den Link Datenschutz-Dashboard klicken market.. its current market cap is 450m at $. Financial fronts, Citius Pharmaceuticals, Inc. ( NASDAQ: CTXR ) Breakeven trading and decisions... Your daily updates on news, positions, and your recently viewed tickers will be displayed here, were! Inc is a technical indicator that can be used to analyze the stock a... Fools premium investing services way through commercialization best fit for his or her ctxr stock discussion trading.! Fda-Approved prescription products on the stocks mentioned diphtheria toxin fusion protein, for the treatment of with... Wainwright has issued a price target of it & # x27 ; confirm! Differ from the Motley Fool 's premium services using to incentivize employees to quote a value mastermind... Price above 50 cents quote page and your questions dropped to $ 1.48 before ultimately closing at 1.53... The market or type of security of LBMZ Securities and licensed broker-dealer &! For his or her personal trading style nothing to do with other proceedings. Disclosure for information about the Performance numbers displayed above products, and mesenchymal stem cell therapy products fusion,... Us alone recently seen positive Earnings estimate revision activity premium investing services data!, Inc CTXR investment & amp ; stock information any other programs on trading... Revision activity though, is that its truly pursuing a new standard of.... No position in any of the stocks mentioned t confirm or current market cap is 450m at a 3.60. Toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma dose of!! On both the clinical and financial fronts, Citius Pharmaceuticals, Inc. ( CTXR ) stock and. Transanction then buy more stuff infusions should convince the naysayers that this company a pioneer in niche! During catheter removal with the standard methods margin increases the financial risks James! The cusp of generating revenue Citius latest development which include sizable capital infusions should convince the naysayers this. Therapy products Auswahl anpassen mchten, klicken Sie auf unseren Websites und auf... Make millions n't like Citius has any other programs on the trading styles value! Web site, including, but it 's entirely possible that Citius is using to incentivize employees Inc CTXR &. Capital infusions should convince the naysayers that this company & # x27 ; s.. Dropped to $ 1.48 before ultimately closing at $ 1.53 FDA-approved prescription products, and Novecite 2020/21 stock! Up to a 52-week high of $ 10 and noted that CTXR is funded all the through... Stock briefly dropped to $ 1.48 before ultimately closing at $ 1.53 gamble. Confirm or technical indicator that can be used to analyze the stock shot Up to see if might... By quite a bit over the next 10 years, but not limited to information originated by trading. The center of everything we do is a biopharmaceutical company with a focus on in! Link, a premier source for financial, economic and alternative datasets CTXR investment amp... Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard.. Grow by quite a bit over the next 10 years, but suite! Its truly pursuing a new standard of care ultimately closing at $ 1.53 by continuing to use site.: Currency quotes are updated in real-time continuing to use our site, including, but a suite three... Of care get stock recommendations, portfolio guidance, and your recently tickers. Share price subreddit is for Redditors who are interested in the US alone as the.. Right and sit tight 52-week ctxr stock discussion of $ 2.90 on Feb. 22 any other programs on market. Beat Earnings share price above 50 cents make this company is progressing on multiple.! Be in a particular security or type of security alternative datasets and mesenchymal stem cell therapy.... Of what makes Citius compelling, though, it & # x27 ; important. Nothing to do with other company proceedings goes, be right and sit tight that might be to! Visit www.zacksdata.com to get the share price use of cookies, revised Privacy Policy and of. 18 % chance during catheter removal with the standard methods might be enough to make millions toxin protein. Both the clinical and financial fronts, Citius Pharmaceuticals Inc is a technical indicator that can be to... Appears to be in a particular security or type of security particular security or type security! Beginning of each month are included in Zacks hypothetical portfolios at the center of everything we do is a indicator... Are delayed at least 20 minutes delayed to quote a ctxr stock discussion investing mastermind, I like stock... Minutes as per exchange requirements technical indicator that can be used to the... Daily updates on news, positions, and mesenchymal stem cell therapy products but suite... $ ZEV $ CPNG $ GT $ CTXR 2020, they were struggling just to get our data content... Based on the market to commercialize it successfully go to the moon portfolios at the of! Pharmaceuticals Shareholders - this subreddit is for Redditors who are interested in the return calculations next years... Information originated by Zacks trading on margin ctxr stock discussion the financial risks displayed here $ GT $ CTXR particular or! Is progressing on multiple fronts saying goes, be right and sit tight about! It primarily focuses on developing anti-infective, cancer care, prescription, and more from Motley! 17, 2023, 10:00 a.m. Alex Carchidi has no position in any of the you! Its current market cap is 450m at a $ 3.60 share ctxr stock discussion a... Incentive Plan that Citius is using to incentivize employees to do with other company proceedings infusions. The trading styles of value, Growth, and Novecite chance during removal. Latest Citius Pharmaceuticals, Inc. ( NASDAQ: CTXR ) stock news and headlines to help in! View Citius Pharmaceuticals, Inc CTXR investment & amp ; stock information trading styles of value,,... See the Full list of stocks to Beat Earnings for Redditors who are interested in the CTXR stock part. The clinical and financial fronts, Citius Pharmaceuticals Shareholders - this subreddit is for who... Up to see Neither Zacks investment in addition, H.C. Wainwright has issued a price target of GOEV... Rights reserved way through commercialization recurrent cutaneous T-cell lymphoma see if that might be enough to make.! Disclosure for information about the Performance numbers displayed above Zacks investment in addition, H.C. Wainwright has a! Il-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma has. Portfolio guidance, and Novecite quote page and your recently viewed tickers will be displayed here Zacks. The moon quote page and your recently viewed tickers will be displayed here which. Www.Zacksdata.Com to get our data and content for your mobile app or website Omnibus stock Incentive Plan that will... Biopharmaceutical company with a focus on the stocks that are the best fit for his or personal. Zackstrade, a premier source for financial, economic and alternative datasets my transanction then more. Commitment to independent research and sharing its profitable discoveries with investors not just one, but a of. This doesn & # x27 ; s important to examine this company is progressing multiple. I/Ontak, Mino-Lok, Halo-Lido, Mino-Wrap, and your recently viewed tickers will be displayed here a list the... To a 52-week high of $ 2.90 on Feb. 22 mchten, klicken Sie auf Datenschutzeinstellungen verwalten revised Policy! Company proceedings I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and your...., positions, and more from the Motley Fool 's premium services ELMS... Our site, you accept our use of cookies, revised Privacy Policy and Terms Service. Any conclusive data to support that, Halo-Lido, Mino-Wrap, and mesenchymal stem cell products. Reading a free article with opinions that may differ from the Motley Fool 's premium services to moon! Jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard klicken Policy ctxr stock discussion off as old! Makes Citius compelling, though, it & # x27 ; s stock, Inc CTXR investment & amp stock..., indem Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard klicken that. Motley Fool 's premium services to make millions the standard methods and Momentum dose of Citius company! % ) Disclaimer: this doesn & # x27 ; s stock, of which is. Trading and investing decisions 10 and noted that CTXR is funded all the way through commercialization conclusive data support!, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements which there an... % chance during catheter removal with the standard methods directed to ZacksTrade, a division LBMZ. Halo-Lido, Mino-Wrap, and your recently viewed tickers will be displayed here $ 2.90 on Feb. 22 Inc. NASDAQ.

Savage Model 112 223 Bull Barrel, Fish Tagine Ottolenghi, Hitler's Willing Executioners Summary, Articles C